nach oben

Erschienen in:

27.05.2022 | Review

A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP)

verfasst von: Parhom Towfighi, Romina Deldar, Zoe K. Haffner, Nathan Aminpour, Olutayo Sogunro, Areeg A. Abu El Hawa, Marc Boisvert, Kenneth L. Fan

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

There is a paucity of literature comparing the postoperative outcomes of males and females with breast cancer who undergo mastectomy. The aim of this study is to evaluate the comorbidities and 30-day post-mastectomy complication rates among males and females.

Methods

We performed a retrospective analysis of breast cancer patients who underwent mastectomy from 2014 to 2016 using the American College of Surgeon's National Surgical Quality Improvement Project database. Data including patient demographics, comorbidities, and 30-day surgical and medical complications were collected. Statistical analysis included Chi-square and Fisher’s exact tests for categorical variables and Student T-tests for continuous variables. Statistical significance was defined as p < 0.05.

Results

A total of 15,167 patients were identified. There were 497 males (3.3%) and 14,670 females (96.7%). Age was significantly higher in females compared to males (63.5 vs. 57.6 years, p < 0.001). Body mass index (BMI) at time of surgery was also higher in males (30.0 vs. 29.3 kg/m², p = 0.011). There was a higher prevalence of diabetes in males (20.1 vs. 16.5%, p = 0.032). Operative duration was significantly longer in females (114.9 vs. 95.0 min, p < 0.001). Median postoperative length of stay was also longer in females (1.2 vs. 0.8 days, p < 0.001). There were no significant differences in 30-day medical or surgical complication rates between the two sexes.

Conclusion

Our findings suggest that differences in age, BMI, and comorbidities between males and females do not significantly impact 30-day medical or surgical complications following total mastectomy for breast cancer. Further research is warranted to identify perioperative risk factors that influence post-mastectomy complication rates.

Level of evidence

3 (Retrospective cohort study)

Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660CrossRefPubMed

Burga AM, Fadare O, Lininger RA, Tavassoli FA (2006) Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases. Virchows Arch 449(5):507–512. https://doi.org/10.1007/s00428-006-0305-3CrossRefPubMedPubMedCentral

Banys-Paluchowski M, Burandt E, Banys J et al (2016) Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: a case report and review of the literature. World J Clin Oncol 7(5):420–424. https://doi.org/10.5306/wjco.v7.i5.420CrossRefPubMedPubMedCentral

White J, Kearins O, Dodwell D, Horgan K, Hanby AM, Speirs V (2011) Male breast carcinoma: increased awareness needed. Breast Cancer Res 13(5):219. https://doi.org/10.1186/bcr2930CrossRefPubMedPubMedCentral

Breast Cancer in Men. American Cancer Society. https://www.cancer.org/cancer/breast-cancer-in-men.html. Accessed 17 Feb 2022

Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367(21):1998–2005. https://doi.org/10.1056/NEJMoa1206809CrossRefPubMed

Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367(9510):595–604. https://doi.org/10.1016/s0140-6736(06)68226-3CrossRefPubMed

Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678–687. https://doi.org/10.7326/0003-4819-137-8-200210150-00013CrossRefPubMed

Uslukaya Ö, Gümüş M, Gümüş H, Bozdağ Z, Türkoğlu A (2016) The management and outcomes of male breast cancer. J Breast Health 12(4):165–170. https://doi.org/10.5152/tjbh.2016.3073CrossRefPubMedPubMedCentral

10.

Thomas E (2010) Original research: Men's awareness and knowledge of male breast cancer. Am J Nurs 110(10):32–7, 39–40; quiz 41–2. https://doi.org/10.1097/01.NAJ.0000389672.93605.2f

11.

Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811–1814. https://doi.org/10.1093/jnci/djm203CrossRefPubMed

12.

Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25(43):5912–5919. https://doi.org/10.1038/sj.onc.1209877CrossRefPubMed

13.

Brinton LA (2011) Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr 100(6):814–818. https://doi.org/10.1111/j.1651-2227.2010.02131.xCrossRefPubMedPubMedCentral

14.

Dimitrakakis C, Bondy C (2009) Androgens and the breast. Breast Cancer Res 11(5):212. https://doi.org/10.1186/bcr2413CrossRefPubMedPubMedCentral

15.

Thomas DB, Jimenez LM, McTiernan A et al (1992) Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 135(7):734–748. https://doi.org/10.1093/oxfordjournals.aje.a116360CrossRefPubMed

16.

Fogh S, Kachnic LA, Goldberg SI, Taghian AG, Powell SN, Hirsch AE (2013) Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Clin Breast Cancer 13(5):344–349. https://doi.org/10.1016/j.clbc.2013.05.004CrossRefPubMed

17.

Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114–2122. https://doi.org/10.1200/jco.2009.25.5729CrossRefPubMedPubMedCentral

18.

Kinne DW (1991) Management of male breast cancer. Oncology (Williston Park) 5(3):45–47 (discussion 47-8)

19.

Eck DL, Koonce SL, Goldberg RF et al (2012) Breast surgery outcomes as quality measures according to the NSQIP database. Ann Surg Oncol 19(10):3212–3217. https://doi.org/10.1245/s10434-012-2529-6CrossRefPubMed

20.

American Medical Association (2007) Surgery: integumentary system. CPT Assist Newslett 17(12):7

21.

American Medical Association (2015) Coding brief: coding for breast surgery. CPT Assist Newslett 25(3):5–11

22.

Coding brief: Coding for breast surery. American Medical Association. https://www.ama-assn.org/practice-management/cpt/cpt-coding-support-latest-guidance-and-best-practices

23.

Karlsson CT, Malmer B, Wiklund F, Grönberg H (2006) Breast cancer as a second primary in patients with prostate cancer–estrogen treatment or association with family history of cancer? J Urol 176(2):538–543. https://doi.org/10.1016/j.juro.2006.03.036CrossRefPubMed

24.

Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97(16):1204–1210. https://doi.org/10.1093/jnci/dji240CrossRefPubMed

25.

Swerdlow AJ, Bruce C, Cooke R et al (2021) Obesity and BREAST CANCER RISK IN MEN: A National Case-Control Study in England and Wales. JNCI Cancer Spectr. https://doi.org/10.1093/jncics/pkab078CrossRefPubMedPubMedCentral

26.

Rifkin WJ, Kantar RS, Cammarata MJ et al (2019) Impact of diabetes on 30-day complications in mastectomy and implant-based breast reconstruction. J Surg Res 235:148–159. https://doi.org/10.1016/j.jss.2018.09.063CrossRefPubMed

27.

Kapoor R, Kumar J, Abhishek, Singh SK (2012) Complications during surgery in chronic kidney disease patients. Clin Queries Nephrol 1(3):241–245. https://doi.org/10.1016/j.cqn.2012.06.008CrossRef

28.

Butterworth J, James R, Prielipp R, Cerese J, Livingston J, Burnett D (2000) Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical Benchmarking Database Participants. Anesthesiology 92(2):414–424. https://doi.org/10.1097/00000542-200002000-00023CrossRefPubMed

29.

Olsen MA, Nickel KB, Fox IK et al (2015) Incidence of surgical site infection following mastectomy with and without immediate reconstruction using private insurer claims data. Infect Control Hosp Epidemiol 36(8):907–914. https://doi.org/10.1017/ice.2015.108CrossRefPubMedPubMedCentral

30.

Murphy BL, Glasgow AE, Habermann EB, Hieken TJ (2019) Returns to the operating room after breast surgery at a tertiary care medical center. Am J Surg 218(2):388–392. https://doi.org/10.1016/j.amjsurg.2019.02.026CrossRefPubMed

31.

Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 20(10):3212–3217. https://doi.org/10.1245/s10434-013-3116-1CrossRefPubMed

Titel: A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP)
verfasst von: Parhom Towfighi
Romina Deldar
Zoe K. Haffner
Nathan Aminpour
Olutayo Sogunro
Areeg A. Abu El Hawa
Marc Boisvert
Kenneth L. Fan
Publikationsdatum: 27.05.2022
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2022
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-022-06628-x

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP)